These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6571502)

  • 1. Mydriasis--use of phenylephrine (a dose-response concept).
    Chawdhary S; Angra SK; Zutshi R; Sachdev MS
    Indian J Ophthalmol; 1984; 32(4):213-6. PubMed ID: 6571502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical stress monitoring during cataract surgery; phenylephrine 10% shows no changes in serum-catecholamines in comparison with phenylephrine 5%].
    Schlichtenbrede FC; Burkhardt KU; Bartram MC; Wiedemann R
    Klin Monbl Augenheilkd; 2001 Jul; 218(7):479-83. PubMed ID: 11512247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of intracameral mydriasis in phacoemulsification cataract surgery.
    Soong T; Soultanidis M; Claoué C; Gallagher M; Thomson S
    J Cataract Refract Surg; 2006 Mar; 32(3):375-6. PubMed ID: 16631031
    [No Abstract]   [Full Text] [Related]  

  • 4. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mydriatics on intraocular pressure and pupil size in the normal feline eye.
    Stadtbäumer K; Frommlet F; Nell B
    Vet Ophthalmol; 2006; 9(4):233-7. PubMed ID: 16771758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the cardiovascular effects of 2.5% phenylephrine and 10% phenylephrine during ophthalmic surgery.
    Malhotra R; Banerjee G; Brampton W; Price NC
    Eye (Lond); 1998; 12 ( Pt 6)():973-5. PubMed ID: 10325999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mydriasis. A comparison between Cyclogyl and Metaoxedrin].
    Bergaust B
    Tidsskr Nor Laegeforen; 1967 Aug; 87(16):1337-9. PubMed ID: 5599190
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery.
    Mouly S; Mahé I; Haouchine B; Sanson-le-Pors MJ; Blain P; Tillet Y; Dewailly J; Mongold JJ; Bergmann JF
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):547-54. PubMed ID: 16700815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular and pupillary effects of topical ophthalmic 2.5 and 10.0% phenylephrine in healthy volunteers].
    Diniz Filho A; Frasson M; Mérula RV; Morais PR; Cronemberger S
    Arq Bras Oftalmol; 2007; 70(6):961-6. PubMed ID: 18235907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular effects of mydriatics in low-birth-weight infants.
    Isenberg S; Everett S
    J Pediatr; 1984 Jul; 105(1):111-2. PubMed ID: 6737125
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenylephrine prodrug. Report of clinical trials.
    Miller-Meeks MJ; Farrell TA; Munden PM; Folk JC; Rao C; Schoenwald RD
    Ophthalmology; 1991 Feb; 98(2):222-6. PubMed ID: 2008281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Exploration of adrenergic receptors in man. II. The test of mydriasis caused by phenylephrine].
    Hugues FC; Baillet J; Marche J
    Therapie; 1972; 27(5):809-19. PubMed ID: 4405587
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects on pupil size and accommodation of sympathetic and parasympatholytic agents.
    Paggiarino DA; Brancato LJ; Newton RE
    Ann Ophthalmol; 1993 Jul; 25(7):244-9, 253. PubMed ID: 8363290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical 2.5% and 5% phenylephrine: comparison of effects on heart rate and blood pressure.
    Hakim OJ; Orton RB; Cadera W
    Can J Ophthalmol; 1990 Dec; 25(7):336-9. PubMed ID: 2090337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged unilateral mydriasis after nasotracheal intubation.
    Louis F; Diab M
    Middle East J Anaesthesiol; 1988 Jun; 9(5):471. PubMed ID: 3193932
    [No Abstract]   [Full Text] [Related]  

  • 16. Mydriatic effect of phenylephrine 10% (aq) vs phenylephrine 2.5% (aq).
    Neuhaus RW; Hepler RS
    Ann Ophthalmol; 1980 Oct; 12(10):1159-60. PubMed ID: 7283322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of topical anesthetics on phenylephrine-induced mydriasis.
    Lyle WM; Bobier WR
    Am J Optom Physiol Opt; 1977 May; 54(5):276-81. PubMed ID: 900246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of topical phenylephrine hydrochloride in the normal human eye.
    Matsumoto S; Tsuru T; Araie M; Komuro Y
    Jpn J Ophthalmol; 1982; 26(3):338-44. PubMed ID: 7154428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased blood pressure following pupillary dilation with 2.5% phenylephrine hydrochloride in preterm infants.
    Lees BJ; Cabal LA
    Pediatrics; 1981 Aug; 68(2):231-4. PubMed ID: 7267230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative dilated pupil during nasal polypectomy.
    Jindal M; Sharma N; Parekh N
    Eur Arch Otorhinolaryngol; 2009 Jul; 266(7):1035-7. PubMed ID: 18688629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.